Coronavirus India: New 46,232 infections, 564 deaths in 24 hours; case tally reaches 90.50 lakh
India has already started working on a COVID-19 vaccine distribution plan to ensure it can "administer the vaccine at the first available opportunity" to its healthcare workers and elderly people amid reports of some vaccines showing promising results.
As India begins to work on its COVID-19 vaccine distribution strategy, fresh 46,232 coronavirus infections and 564 new deaths have been recorded in the last 24 hours, taking the total case tally to 90.50 lakh. The death toll stands at 1,32,726, according to the Union Health Ministry on Saturday.
Over 84.78 lakh people have recovered from the novel coronavirus, pushing the national recovery rate to 93.67 per cent. The total coronavirus cases mounted to 90,50,597 while the number of active cases remained below five lakh for the 11th consecutive day.
????#CoronaVirusUpdates:— #IndiaFightsCorona (@COVIDNewsByMIB) November 21, 2020
????#COVID19 India Tracker
(As on 21 November, 2020, 08:00 AM)
➡️Confirmed cases: 90,50,597
➡️Recovered: 84,78,124 (93.67%)????
➡️Active cases: 4,39,747 (4.86%)
➡️Deaths: 1,32,726 (1.47%)#IndiaFightsCorona#Unite2FightCorona#StaySafe
Via @MoHFW_INDIA pic.twitter.com/PnIZJxd5lj
#CoronaVirusUpdates:— #IndiaFightsCorona (@COVIDNewsByMIB) November 21, 2020
State-wise details of Total Confirmed #COVID19 cases
(till 21st November, 2020, 8 AM)
➡️States with 1-30000 confirmed cases
➡️States with 30001-225000 confirmed cases
➡️States with 225000+ confirmed cases
➡️Total no. of confirmed cases so far pic.twitter.com/o6yR9n4bfs
There are 4,39,747 active cases of coronavirus infection in the country as on date, which comprises 4.86 per cent of the total caseload, as per the data. The COVID-19 case fatality rate stands at 1.47 per cent.
According to ICMR, over 13.06 crore samples have been tested till November 20 with 10,66,022 samples being tested on Friday.
#CoronaVirusUpdates:#COVID19 testing status update:@ICMRDELHI stated that 13,06,57,808 samples tested upto November 20, 2020.— #IndiaFightsCorona (@COVIDNewsByMIB) November 21, 2020
10,66,022 samples tested on November 20, 2020.#StaySafe #IndiaWillWin #Unite2FightCorona pic.twitter.com/KQ15UeGN8r
INDIA'S VACCINE DISTRIBUTION PLAN
India has started working on a COVID-19 vaccine distribution plan to ensure it can "administer the vaccine at the first available opportunity" to its healthcare workers and elderly people amid reports of some vaccines showing promising results.
Prime Minister Narendra Modi on Friday held a meeting to review India's COVID-19 vaccination strategy in which issues like prioritisation of population groups, including health and other frontline workers, and tech platform for rolling out the vaccine were discussed.
Held a meeting to review India’s vaccination strategy and the way forward. Important issues related to progress of vaccine development, regulatory approvals and procurement were discussed. pic.twitter.com/nwZuoMFA0N— Narendra Modi (@narendramodi) November 20, 2020
The Prime Minister directed that a time-bound plan be laid out for speedy regulatory clearances and timely procurement for early roll-out of the vaccination drive when a vaccine becomes available, an official statement later said.
Database, cold chain augmentation and transportation mechanisms are being readied, with digital platform for vaccine delivery and monitoring being prepared and tested in consultation with all stakeholders, it said.
Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II.
Vaccine maker Serum Institute of India's CEO Adar Poonawalla has said the Oxford COVID-19 vaccine should be available for the country's vulnerable population by February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public.
Globally, COVID-19 has infected more than 57.4 million people, while 1.3 million have died since the disease first emerged in China's Wuhan late last year.
According to the World Health Organisation, Europe remains the hardest-hit region, accounting for 46 per cent of new global cases and 49 per cent deaths in mid-November.